Course Information

18th Annual HIV CME Symposium: Tough Decisions Made Easier

Live Virtual Learning

November 12, 2021

*Please note that the course syllabus will be available online only to registered attendees.
A password link will be sent prior to the course.

Syllabus for Conference Registrants

Download: [ PDF ]

This one-day virtual symposium is designed to provide participants with relevant, reliable, up-to-date information on the clinical management of HIV-related issues including: management of people with HIV with new or simplified treatment options, or who have demonstrated some degree of resistance to one or more antiretroviral drugs, and the use of antivirals for the prevention of HIV in those at-risk.

About the Center for Clinical AIDS Research and Education

UCLA has been a leader in AIDS and HIV-related research, education and patient care since 1981 when the nation’s first cases of AIDS were identified at the UCLA Medical Center. The UCLA Center for Clinical AIDS Research and Education (CARE Center) was established in 1990 to facilitate clinical research and to integrate current research findings with teaching and patient care.

The UCLA CARE Center manages an outpatient clinic dedicated to patients with or at-risk for HIV and maintains an active clinical research program, which evaluates new antiretroviral therapies and preventive interventions, and investigates diseases associated with HIV and the complications of therapy. It is one of the original sites of the Adult AIDS Clinical Trials Group (ACTG) and the AIDS Malignancy Consortium (AMC). An education and outreach program disseminates information on AIDS and HIV infection to healthcare providers and to the community.

The CARE Center is also a primary location for training of medical students and house staff at the David Geffen School of Medicine at UCLA in the optimal care of patients with HIV.

About the Los Angeles Region Pacific AIDS Education Training Center

The Los Angeles Region Pacific AIDS Education and Training Center (LA PAETC) provides direct educational services to a broad range of health providers in Southern California and has developed web-based learning modules available at https://hivtrainingcdu.remote-learner.net/. The PAETC also sponsors a free telehealth HIV mentoring program for HIV clinical care teams and individual clinicians that can be found here.

The LA PAETC provides HIV providers (physicians, physician assistants, nurses, nurse practitioners, dentists, dental hygienists, pharmacists, case managers, mental health providers and others) with the knowledge and skills necessary to care for HIV-infected patients and increases the number of trained primary care professionals working with HIV-infected patients in the community. Training programs are designated by level, according to the experience, knowledge and needs of trainees.

The AIDS Education and Training Centers also offer a national AIDS "Warmline" consultation service for physicians, pharmacists and other health professionals (800-933-3413) as well as a 24-hour hotline (888-448-4911) for Post-Exposure Prophylaxis (PEP) and a National Perinatal HIV Consultation and Referral Service (800-448-8765). Although our experts cannot offer opinions with regard to specific patients, they can respond to general questions with regard to diagnosis and management. For more information on the LA PAETC, please call Tom Donohoe at (310) 794-8276.

About the UCLA AIDS Institute

In 1981, UCLA physicians reported the very first cases of what they described as “newly acquired immunodeficiency”-what we now know as AIDS. These doctors’ discovery and the subsequent exponential explosion of AIDS cases in Los Angeles and elsewhere around the country and around the world, led to the formation of the widely-acclaimed UCLA AIDS Institute in 1992. Under the direction of Dr. Irvin S.Y. Chen, an internationally respected virologist, the UCLA AIDS Institute provides a multidisciplinary think-tank for top-flight researchers who are assailing HIV on many fronts.

Institute members include faculty who work in the fields of virology and immunology, genetics, cancer, neurology, ophthalmology, epidemiology, social science, public health, nursing, and disease prevention. Their studies are carried out at the UCLA Westwood campus, in community settings, at half a dozen major medical centers in greater Los Angeles, and at scores of locations in India, China, Brazil, and sub-Saharan Africa.

Through laboratory research leading to new treatments for HIV, providing outstanding care to patients with HIV and developing more effective prevention strategies, the UCLA AIDS Institute is leading the worldwide effort to eradicate HIV and AIDS. The Institute’s dedicated scientists are committed to developing more effective education and prevention strategies for at-risk communities around the world, and better treatments for all people living with HIV. Innovative research programs that aim to develop a safe and effective HIV vaccine are among the UCLA AIDS Institute’s very highest priorities.

Offered Entirely Remotely!

The 18th Annual HIV CME Symposium: Tough Decision Made Easier will be available through a live virtual meeting web platform.

  • Registrants will be able to participate live in the 18th Annual HIV CME Virtual Symposium.
  • Registrants will receive a virtual meeting link and password to access the virtual conference.
  • Registrants will be provided the opportunity to review recorded sessions up to 3 weeks following the conference.

Enrollment

*Note: To ensure course material is received before the course begins, early registration is advised. Online registration will close at 11:59 PM on Thursday, November 11th.

Enrollment on the day(s) of the course: Registration will only be accepted between 9:30 AM - 10:30 AM (Pacific Standard Time). Please call (512) 270-8113 or email us at UCLACME@mednet.ucla.edu to enroll.

Course Fees

  • General Admission: $45.00

Enroll Online

To enroll click here.

By Phone

Call (310) 794-2620 and use your American Express, MasterCard, VISA or Discover card.

By Fax

Complete the enrollment form and all of the requested credit card information, including an authorizing signature, and fax the form to (310) 794-2624.

By Mail

Complete the attached form and mail to:
Tough Decisions Made Easier
Office of Continuing Medical Education
David Geffen School of Medicine at UCLA
10920 Wilshire Boulevard, Suite 1060
Los Angeles, CA 90024-6512

Refunds

Cancellations must be received in writing by November 1, 2021 and will be subject to a $20 processing fee. No refunds will be granted after that date. If, for any reason, the course must be cancelled, discontinued, or rescheduled by the Office of Continuing Medical Education, a full refund will be provided.

PROGRAM CHAIRS

JUDITH S. CURRIER, MD
Professor of Medicine
Chief, Division of Infectious Diseases
Director, Center for Clinical AIDS Research and Education
David Geffen School of Medicine at UCLA
Los Angeles, CA

RAPHAEL J. LANDOVITZ, MD, MSc
Professor of Medicine
Division of Infectious Diseases
Co-Director, Center for Clinical AIDS Research and Education
David Geffen School of Medicine at UCLA
Los Angeles, CA

COURSE FACULTY

KARA CHEW, MD, MS
Associate Clinical Professor of Medicine
Division of Infectious Diseases
David Geffen School of Medicine at UCLA
Center for Clinical AIDS Research and Education
Los Angeles, CA

JESSE CLARK, MD, MSc
Associate Professor-in-Residence
Division of Infectious Diseases
David Geffen School of Medicine at UCLA
Los Angeles, CA

SUSA COFFEY, MD
Professor of Medicine
Division HIV, Infectious Diseases, and Global Medicine at San Francisco General Hospital
San Francisco, CA

MONICA GANDHI, MD, MPH
Director, Center for AIDS Research (CFAR) at UCSF
University of California San Francisco
San Francisco, CA

RAPHAEL J. LANDOVITZ, MD, MSc
Professor of Medicine
Division of Infectious Diseases
Co-Director, Center for Clinical AIDS Research and Education
David Geffen School of Medicine at UCLA
Los Angeles, CA

TARA VIJAYAN, MD, MPH
Associate Clinical Professor
Medical Director, Adult Antimicrobial Stewardship Program
Division of Infectious Diseases
David Geffen School of Medicine
Los Angeles, CA

Friday, November 12, 2021

9:30 am PST Welcome & Introduction
Judith Currier, MD
9:40 am Surveying the PrEP Landscape: Current and Future Agents for HIV Pre-Exposure Prophylaxis
Jesse Clark, MD, MSc
10:00 am Question and Answer Session
10:15 am Update on Strategies for an HIV Cure
Kara Chew, MD, MS
10:35 am Question and Answer Session
10:55 am Break and Visit Exhibits
11:10 am Cabenuva in the Clinic: Translating Trials to Practice
Tara Vijayan, MD, MPH
11:30 am Question and Answer Session
11:45 am Lunch Break and Visit Exhibits
12:30 pm HIV/COVID-19 Considerations
Monica Gandhi, MD, MPH
12:50 pm Question and Answer Session
1:05 pm Rapid ART in 2021
Susa Coffey, MD
1:25 pm Question and Answer Session
1:40 pm Closing Remarks
Raphael Landovitz, MD, MSc
1:45 pm Adjourn

At the conclusion of this course, participants should be able to:

  • Implement the service needs of developing long-acting injectable HIV therapies
  • Identify the advantages and disadvantages of currently available PrEP agents
  • Identify the current progress towards HIV cure/ART-free remission
  • Describe challenges of clinical management of COVID-19 infection and risk in the context of HIV infection, and describe the impact of COVID-19 on HIV management

The Office of Continuing Medical Education, David Geffen School of Medicine at UCLA is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Office of Continuing Medical Education, David Geffen School of Medicine at UCLA designates this live activity for a maximum of 3.25 AMA PRA Category 1 Credits TM. Physicians should claim only credit commensurate with the extent of their participation in the activity.

The California State Board of Registered Nursing accepts courses approved by the AMA for category 1 credit as meeting the continuing education requirements for license renewal. Nurses from states other than California should inquire with their local State Board for specific continuing education policies.

The FDA has issued a concept paper which classifies commercial support of scientific and educational programs as promotional unless it can be affirmed that the program is "truly independent" and free of commercial influence. In addition to independence, the FDA requires that nonpromotional, commercially supported education be objective, balanced, and scientifically rigorous. The policy further states that all potential conflicts of interest of the CME staff and faculty be fully disclosed to the program's participants. In addition, Accreditation Council for Continuing Medical Education policy mandates that the provider adequately manages all identified potential conflicts of interest prior to the program. We at UCLA fully endorse the letter and spirit of these concepts.